October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

All 4 codes in the G13 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

4

Can lead a claim

0

Cannot lead a claim

4

What CMS assigns to G13

None of the 4 codes is assigned a clinical group. Comorbidity subgroups: 2 toward Alzheimer’s disease and related dementias; 1 toward Nondiabetic neuropathy; 1 is assigned none. None can lead a claim. CMS attaches a code-first note to all 4.

  • Alzheimer’s disease and related dementias: counts toward the high comorbidity tier only in an interaction pair.
  • Nondiabetic neuropathy: counts toward the high comorbidity tier only in an interaction pair.

Code first

CMS grouper convention 9, on G13.0, G13.1. Code first:

  • neoplasm (C00-D49)

CMS grouper convention 12, on G13.8. Code first:

  • underlying disease

CMS grouper convention 33, on G13.2. Code first:

  • hypothyroidism (E03.-)
  • myxedematous congenital iodine deficiency (E00.1)
  • underlying disease, such as:

Every code in G13

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
G13.0Paraneoplastic neuromyopathy and neuropathyCannot lead a claimManifestation code is not reportable as principal diagnosisNoneNondiabetic neuropathy
G13.1Other systemic atrophy primarily affecting central nervous system in neoplastic diseaseCMS: Oth systemic atrophy aff cnsl in neoplastic diseaseCannot lead a claimManifestation code is not reportable as principal diagnosisNoneNone
G13.2Systemic atrophy primarily affecting the central nervous system in myxedemaCMS: Systemic atrophy primarily affecting the cnsl in myxedemaCannot lead a claimManifestation code is not reportable as principal diagnosisNoneAlzheimer’s disease and related dementias
G13.8Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhereCMS: Systemic atrophy aff cnsl in oth diseases classd elswhrCannot lead a claimManifestation code is not reportable as principal diagnosisNoneAlzheimer’s disease and related dementias

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue